Goutinex

Manufacturer: Hello Life, Inc. | King Bio Inc.
Effective date: 2018-12-26
Label type: HUMAN OTC DRUG LABEL
Version: 10
Source: full-release
Hydrated at: 2026-06-01 02:10:37

Label at a glance#

ProductGoutinex Gout Symptom Relief

Active ingredientACTAEA SPICATA ROOT, AMMONIUM PHOSPHATE, DIBASIC, ATROPA BELLADONNA, COLCHICUM AUTUMNALE BULB, FORMIC ACID, SODIUM CARBONATE, STRYCHNOS NUX-VOMICA SEED, PHYTOLACCA AMERICANA ROOT, RHODODENDRON AUREUM LEAF, SALICYLIC ACID, URTICA URENS, LEDUM PALUSTRE TWIG, FRAXINUS EXCELSIOR LEAF

Label structure12 sections

Indications and uses

to temporarily relieve symptoms commonly associated with gout, such as exhaustion dullness drowsiness muscle weakness

Dosage and administration

Dispense Goutinex directly into mouth, or add recommended dosage into 8-12 oz. of purified (non-chlorinated) water and drink. Safe for ages 2 and up.

Storage and handling

do not use if tamper seal is broken store in a cool, dry place product must not come in contact with metal do not store next to electrical devices or appliances

Contacts and useful links#

PhoneLabel contact1.800.875.0850

Websitewww.goutinex.com

www.goutinex.com

Label contents#

Full prescribing information#

Active Ingredients (per dose)

OTC - ACTIVE INGREDIENT SECTION

Actaea spicata HPUS
Ammonium phoshoricum HPUS
Belladonna HPUS
Colchicum autumnale HPUS
Formicum acidum HPUS
Fraxinus excelsior HPUS
Ledum palustre HPUS
Natrum carbonicum HPUS
Nux vomica HPUS
Phytolacca decandra HPUS
Rhododendron chrysanthum HPUS
Salicylicum acidum HPUS
Urtica urens HPUS

Each active ingredient contains equal volumes of 10X, 30X, and LM1 potencies.
The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.
Product indications are based on Homeopathic Materia Medica.

Active Ingredients (per dose)

OTC - ACTIVE INGREDIENT SECTION


Actaea spicata HPUS Ammonium phoshoricum HPUS Belladonna HPUS Colchicum autumnale HPUS Formicum acidum HPUS Fraxinus excelsior HPUS Ledum palustre HPUS Natrum carbonicum HPUS Nux vomica HPUS Phytolacca decandra HPUS Rhododendron chrysanthum HPUS Salicylicum acidum HPUS Urtica urens HPUS Each active ingredient contains equal volumes of 10X, 30X, and LM1 potencies. The letters “HPUS” indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. Product indications are based on Homeopathic Materia Medica.

Purpose

OTC - PURPOSE SECTION

Actaea spicata HPUS..……………………….Pain
Ammonium phoshoricum HPUS…......……..Heaviness of limbs
Belladonna HPUS……………………….…...Swelling
Colchicum autumnale HPUS………….........Numbness
Formicum acidum HPUS…………………....Gout
Fraxinus excelsior HPUS.…………………..Rheumatism
Ledum palustre HPUS.………………………Pain in joints
Natrum carbonicum HPUS………..………...Cramping in feet and toes
Nux vomica HPUS……………………………Spasms
Phytolacca decandra HPUS………………...Soreness
Rhododendron chrysanthum HPUS……......Stiffness
Salicylicum acidum HPUS……………………Burning
Urtica urens HPUS…………………………….Trouble sleeping

Uses

INDICATIONS & USAGE SECTION

to temporarily relieve symptoms commonly associated with gout, such as

exhaustion
dullness
drowsiness
muscle weakness

Warnings

WARNINGS SECTION

Ask a doctor before use if

you are taking any other medications
you have a medical condition

OTC - WHEN USING SECTION

When using this product, use only as directed.

OTC - STOP USE SECTION

Stop use and ask a doctor if symptoms persist or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, take only on advice of physician.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children.

Directions

DOSAGE & ADMINISTRATION SECTION

Dispense Goutinex directly into mouth, or add recommended dosage into 8-12 oz. of purified (non-chlorinated) water and drink. Safe for ages 2 and up.

DOSAGE BY WEIGHT

DOSAGE FORMS & STRENGTHS SECTION

30-50 lbs 1/2 mL
(13.6-22.6 kg) twice per day

50+ lbs 1 mL
(22.6+ kg) twice per day

Other information

STORAGE AND HANDLING SECTION

do not use if tamper seal is broken

store in a cool, dry place

product must not come in contact with metal

do not store next to electrical devices or appliances

Inactive Ingredients

INACTIVE INGREDIENT SECTION

citric acid, potassium sorbate, purified ionized mineral water.

Questions or comments?

OTC - QUESTIONS SECTION

You can email us at info@hellolife.net or call us toll-free at 1.800.875.0850 Monday through Friday, 9am-5pm ET.

DESCRIPTION SECTION

30-day supply
dropper included
Goutinex is made without alcohol or sugar; no gluten added.

Mftd for: HelloLife, Inc.
4460 44th St. SE, Ste. C-600
Grand Rapids, MI 49512
FDA Pharmaceutical Establishment
#1053442, #3009727070
www.goutinex.com

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 49726-023-02

GOUTINEX™

Gout Symptom Relief

To temporarily relieve symptoms commonly associated with gout, such as:

joint pain
stiffness
inflammation
swelling

Homeopathic (OTC) Medicine
2 fl oz (59 mL)

GoutinexCarton

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
efd58dcf-540a-4531-8766-e713129ca6f2	Product name	1	20250307
4b7700e3-6e0e-45e5-9d22-6f754d61386e	Product name	2	20250304
726062af-1135-4707-a1d7-57256991bbf9	Product name	2	20250226
dea2eded-d1e7-46bb-9a3d-f8dc20de6277	Product name	1	20190408
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
19c71a3d-ed9c-166b-a7e5-38c250c35631	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
49726-023-02	2020-01-31	C162847	48780-1	9d75b9d1-23ca-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
49726-023-02	GoutinexGout Symptom Relief	59 mL in 1 BOTTLE, DROPPER	LIQUID	59		10
49726-023-02	GoutinexGout Symptom Relief	1 in 1 CARTON	LIQUID	1		10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
49726-023	GOUTINEX GOUT SYMPTOM RELIEF (ACTAEA SPICATA, AMMONIUM PHOSPHORICUM, BELLADONNA, COLCHICUM AUTUMNALE, FORMICUM ACIDUM, FRAXINUS EXCELSIOR, LEDUM PALUSTRE, NATRUM CARBONICUM, NUX VOMICA, PHYTOLACCA DECANDRA, RHODODENDRON CHRYSANTHUM, SALICYLICUM ACIDUM, URTICA URENS) LIQUID [HELLO LIFE, INC.]	10	Legacy NDC, 2 package rows	20181227_4243e27f-ce96-4e73-9948-be88c5d02726.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACTAEA SPICATA ROOT	ACTIVE INGREDIENT	3FU86L9OS0	6
AMMONIUM PHOSPHATE, DIBASIC	ACTIVE INGREDIENT	10LGE70FSU	6
ATROPA BELLADONNA	ACTIVE INGREDIENT	WQZ3G9PF0H	6
COLCHICUM AUTUMNALE BULB	ACTIVE INGREDIENT	993QHL78E6	6
FORMIC ACID	ACTIVE INGREDIENT	0YIW783RG1	6
FRAXINUS EXCELSIOR LEAF	ACTIVE INGREDIENT	RC38362Q7M	6
LEDUM PALUSTRE TWIG	ACTIVE INGREDIENT	877L01IZ0P	6
PHYTOLACCA AMERICANA ROOT	ACTIVE INGREDIENT	11E6VI8VEG	6
RHODODENDRON AUREUM LEAF	ACTIVE INGREDIENT	IV92NQJ73U	6
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	6
SODIUM CARBONATE	ACTIVE INGREDIENT	45P3261C7T	6
STRYCHNOS NUX-VOMICA SEED	ACTIVE INGREDIENT	269XH13919	6
URTICA URENS	ACTIVE INGREDIENT	IHN2NQ5OF9	6
ACTAEA SPICATA ROOT	ACTIVE MOIETY	3FU86L9OS0	6
ATROPA BELLADONNA	ACTIVE MOIETY	WQZ3G9PF0H	6
CARBONATE ION	ACTIVE MOIETY	7UJQ5OPE7D	6
COLCHICUM AUTUMNALE BULB	ACTIVE MOIETY	993QHL78E6	6
FORMIC ACID	ACTIVE MOIETY	0YIW783RG1	6
FRAXINUS EXCELSIOR LEAF	ACTIVE MOIETY	RC38362Q7M	6
LEDUM PALUSTRE TWIG	ACTIVE MOIETY	877L01IZ0P	6
PHOSPHATE ION	ACTIVE MOIETY	NK08V8K8HR	6
PHYTOLACCA AMERICANA ROOT	ACTIVE MOIETY	11E6VI8VEG	6
RHODODENDRON AUREUM LEAF	ACTIVE MOIETY	IV92NQJ73U	6
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	6
STRYCHNOS NUX-VOMICA SEED	ACTIVE MOIETY	269XH13919	6
URTICA URENS	ACTIVE MOIETY	IHN2NQ5OF9	6
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	6
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	6
WATER	INACTIVE INGREDIENT	059QF0KO0R	6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

Goutinex Gout Symptom Relief
ACTAEA SPICATA, AMMONIUM PHOSPHORICUM, BELLADONNA, COLCHICUM AUTUMNALE, FORMICUM ACIDUM, FRAXINUS EXCELSIOR, LEDUM PALUSTRE, NATRUM CARBONICUM, NUX VOMICA, PHYTOLACCA DECANDRA, RHODODENDRON CHRYSANTHUM, SALICYLICUM ACIDUM, URTICA URENS
WATER
POTASSIUM SORBATE
CITRIC ACID MONOHYDRATE
ACTAEA SPICATA ROOT
AMMONIUM PHOSPHATE, DIBASIC
PHOSPHATE ION
ATROPA BELLADONNA
COLCHICUM AUTUMNALE BULB
FORMIC ACID
SODIUM CARBONATE
CARBONATE ION
STRYCHNOS NUX-VOMICA SEED
PHYTOLACCA AMERICANA ROOT
RHODODENDRON AUREUM LEAF
SALICYLIC ACID
URTICA URENS
LEDUM PALUSTRE TWIG
FRAXINUS EXCELSIOR LEAF

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
49726-023	49726-023-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
WATER	059QF0KO0R	IACT
POTASSIUM SORBATE	1VPU26JZZ4	IACT
CITRIC ACID MONOHYDRATE	2968PHW8QP	IACT
ACTAEA SPICATA ROOT	3FU86L9OS0	ACTIB
AMMONIUM PHOSPHATE, DIBASIC	10LGE70FSU	ACTIB
ATROPA BELLADONNA	WQZ3G9PF0H	ACTIB
COLCHICUM AUTUMNALE BULB	993QHL78E6	ACTIB
FORMIC ACID	0YIW783RG1	ACTIB
SODIUM CARBONATE	45P3261C7T	ACTIB
STRYCHNOS NUX-VOMICA SEED	269XH13919	ACTIB
PHYTOLACCA AMERICANA ROOT	11E6VI8VEG	ACTIB
RHODODENDRON AUREUM LEAF	IV92NQJ73U	ACTIB
SALICYLIC ACID	O414PZ4LPZ	ACTIB
URTICA URENS	IHN2NQ5OF9	ACTIB
LEDUM PALUSTRE TWIG	877L01IZ0P	ACTIB
FRAXINUS EXCELSIOR LEAF	RC38362Q7M	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 107 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / EPIDURAL	0.02 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	CONCENTRATE / ORAL		1 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	SOLUTION / RECTAL	6.67 %w/v		Exact identifier — unii candidate 19 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SWAB / TOPICAL	0.05 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	NA		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / OPHTHALMIC	0.03 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / RESPIRATORY (INHALATION)		8 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	LOTION / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 19 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS		608 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, SOLUTION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	CONCENTRATE / ORAL	5.3 mg/1ml		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SUSPENSION / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	CAPSULE / ORAL		238 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SYRUP / ORAL	722 mg/5ml		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER, FOR SUSPENSION / ORAL		840 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / INTRAOCULAR		1 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOAP / TOPICAL	0.5 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / SUBCUTANEOUS		28 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	TABLET / SUBLINGUAL		24 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	DROPS / ORAL	NA		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	EMULSION / TOPICAL	0.11 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	SUSPENSION / ORAL		400 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	TABLET, FILM COATED / ORAL		42 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / INTRAVENOUS		10 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SUSPENSION / RESPIRATORY (INHALATION)	0.03 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / INTRALESIONAL	ADJ PH		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	CAPSULE, EXTENDED RELEASE / ORAL		101 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	TABLET, CHEWABLE / ORAL	7 mg		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	GEL / TOPICAL		1 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	LIQUID / RESPIRATORY (INHALATION)	0.13 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR		38 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / TOPICAL		17 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, SOLUTION / SUBCUTANEOUS		26 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET, EXTENDED RELEASE / ORAL	0.2 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SYSTEM / TOPICAL	0.2 mg		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	TABLET / ORAL	914 mg		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER, FOR SOLUTION / TOPICAL	NA		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / ORAL		446 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	CREAM / VAGINAL	0.49 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, SOLUTION / INTRAMUSCULAR		26 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / IONTOPHORESIS	0.02 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	AEROSOL, FOAM / RECTAL		7 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	SPRAY, METERED / NASAL	0.06 mg		Exact identifier — unii candidate 19 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR		1 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	GRANULE, FOR SUSPENSION / ORAL		80 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	POWDER, FOR SUSPENSION / ORAL		19 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	ELIXIR / ORAL	100 mg/5ml		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION/ DROPS / OPHTHALMIC	0.05 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SOLUTION / BUCCAL	NA		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	CREAM / TOPICAL		4 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SUSPENSION / ORAL		269 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER, FOR SOLUTION / ORAL		315 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	DOUCHE / VAGINAL	0.07 %w/w		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / INFILTRATION	0.02 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	INJECTION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SHAMPOO, SUSPENSION / TOPICAL	0.25 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	SHAMPOO / TOPICAL		17 mg	Exact identifier — unii candidate 88 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	LIQUID / INTRAVENOUS	0.2 %w/v		Exact identifier — unii candidate 88 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
7df183c1-5f62-1a16-e053-2991aa0a2223			4243e27f-ce96-4e73-9948-be88c5d02726	2018-12-26	Warnings	Exact identifier spl id: 7df183c1-5f62-1a16-e053-2991aa0a2223 spl set id: 4243e27f-ce96-4e73-9948-be88c5d02726

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.